D-0331-2022 Class II Terminated

Recalled by Perrigo Company PLC — Allegan, MI

FDA drug recall D-0331-2022 was initiated by Perrigo Company PLC on Jul 27, 2021 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing. The recall status is terminated (terminated Nov 8, 2022). Affected quantity: 28,320 containers.

Recall details

Product Type
Drugs
Report Date
Jan 12, 2022
Initiation Date
Jul 27, 2021
Termination Date
Nov 8, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
28,320 containers

Product description

basic+care, allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 HR, 150 count bottle, Made in the Czech Republic, Distributed by: Perrigo Allergan, MI 49010, NDC 0113-7571-47 UPC 3 70030 11470 2

Reason for recall

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Distribution pattern

Nationwide in the USA

Code information

Lot # 0GR0528, Exp 03/31/22; 0KR0473, Exp 04/30/22; 0LR0369, Exp 06/30/22

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0331-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0331-2022. Report a data issue: hello@regdatalab.com.